Adelaide Research & Scholarship: Search

Search

Results 1-7 of 7 (Search time: 0.002 seconds).

previous
1
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2005	Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium	Atkins, G.; Kostakis, P.; Welldon, K.; Vincent, C.; Findlay, D.; Zannettino, A.
	2005	Osteoprotegerin (OPG) is localized to the Weibel-Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factor	Zannettino, A.; Holding, C.; Diamond, P.; Atkins, G.; Kostakis, P.; Farrugia, A.; Gamble, J.; To, L.; Findlay, D.; Haynes, D.
	2005	An in vitro osteoclast-forming assay to measure myeloma cell-derived osteoclast-activating factors	Zannettino, A.; Farrugia, A.; To, L.; Atkins, G.; Brown, R.; Joy Ho, P.
	2006	Evidence for reduced bone formation surface relative to bone resorption surface in female femoral fragility fracture patients	Tsangari, H.; Findlay, D.; Zannettino, A.; Pan, B.; Kuliwaba, J.; Fazzalari, N.
	2008	Does Apo2LTRAIL play any physiologic role in osteoclastogenesis?	Labrinidis, A.; Liapis, V.; Thai, L.; Atkins, G.; Vincent, C.; Hay, S.; Sims, N.; Zannettino, A.; Findlay, D.; Evdokiou, A.
	2009	Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancer	Zinonos, I.; Labrinidis, A.; Lee, M.; Liapis, V.; Hay, S.; Ponomarev, V.; Diamond, P.; Zannettino, A.; Findlay, D.; Evdokiou, A.
	2009	Apo2L/TRAIL inhibits tumor growth and bone destruction in a murine model of multiple myeloma	Labrinidis, A.; Diamond, P.; Martin, S.; Hay, S.; Liapis, V.; Zinonos, I.; Sims, N.; Atkins, G.; Vincent, C.; Ponomarev, V.; Findlay, D.; Zannettino, A.; Evdokiou, A.